Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-30

Clinical Trial Update: A Multicenter,Double-Blind and Randomized Controlled Trial of Fengshigutong Capsule in the Treatment of Ankylosing Spondylitis [Phase 4]

View source ↗

Summary

Phase 4 randomized trial evaluating Fengshigutong Capsule for ankylosing spondylitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fengshigutong Capsule

Snippet

Sponsor: Sun Yat-sen University | Conditions: Ankylosing Spondylitis | Phase 4 | Status: UNKNOWN